Lanreotide Induces Cytokine Modulation in Intestinal Neuroendocrine Tumors and Overcomes Resistance to Everolimus

Somatostatin analogs mantain their major role in the treatment of patients with advanced neuroendocrine tumors (NETs) and have multiple modulatory effects on the immune system. Here, we evaluated the effects of lanreotide treatment on expression of Th1, Th2 cytokine patterns in serum of patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Sciammarella, Concetta, Luce, Amalia, Riccardi, Ferdinando, Mocerino, Carmela, Modica, Roberta, Berretta, Massimiliano, Misso, Gabriella, Cossu, Alessia Maria, Colao, Annamaria, Vitale, Giovanni, Necas, Alois, Fedacko, Jan, Galdiero, Marilena, Correale, Pierpaolo, Faggiano, Antongiulio, Caraglia, Michele, Capasso, Anna, Grimaldi, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379869/
https://www.ncbi.nlm.nih.gov/pubmed/32766136
http://dx.doi.org/10.3389/fonc.2020.01047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379869/
https://www.ncbi.nlm.nih.gov/pubmed/32766136
http://dx.doi.org/10.3389/fonc.2020.01047

Ejemplares similares